Skip to content

Clinical trials

Phase 3 Lymphoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 3 Country / region: Netherlands Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20022
20031
20041
20051
20062
20081
20131
20161
20201
20211
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting7
Unknown status5
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC10
Commissie Voor Klinisch Toegepast Onderzoek3
Genmab2
ADC Therapeutics S.A.1
Celgene1
Children's Oncology Group1
Gamida Cell ltd1
Genzyme, a Sanofi Company1
German Hodgkin's Lymphoma Study Group1
Gustave Roussy, Cancer Campus, Grand Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma28
Lymphoma, Follicular10
Hodgkin Disease6
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Non-Hodgkin5
Leukemia3
Lymphoma, Mantle-Cell3
Myelodysplastic Syndromes3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Burkitt Lymphoma2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.